Skip to main content
Log in

The Search for Pharmacologically Active Compounds Among the 2-Dialkylaminobenzimidazoles

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

Heating of substituted benzimidazole-2-sulfonic acids in the presence of excess quantities of secondary amines was used to synthesize dialkylaminobenzimidazoles. Experimental studies of potential antiarrhythmic, antiaggregation, hemorheological, AT1 angiotensin- and NHE-1-inhibiting, and antiserotonin activity identified active compounds. 1[-2-(5-Methyl)benzimidazole]pyrrolidine had greater NHE-inhibiting activity than zoniporide. 1-{[2-(5-Methoxy)benzimidazole]-4-N-methyl}piperazine dihydrochloride had greater antiaggregatory activity than acetylsalicylic acid, while 1-[2-(5-methyl)benzimidazole]piperidine was as active as cyproheptadine in terms of 5-HT2A antagonistic activity. 1-(2-Benzimidazole)pyrrolidine and 1-[2-(5-chloro) benzimadazole pyrrolidine dihydrochlorides had 5-HT3 antagonist activity equal to that of tropisetron..

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. D. A. Horton, G. I. Bourne, and M. L. Smythe, Chem. Rev., 103, 893 (2003).

    Article  CAS  PubMed  Google Scholar 

  2. G. Hakan, A-K. Gulgun, T. Meral, et al., Heterocycles, 51(11), 2561 – 2573 (1999).

    Article  Google Scholar 

  3. A. A. Spasov, M. V. Chernikov, D. S. Yakovlev, and V. A. Anisimova, Khim.-farm. Zh., 40(11), 23 – 26 (2006); Pharm. Chem. J., 40(11), 603 – 606 (2006).

  4. A. A. Spasov and D. S. Yakovlev, Khim.-farm. Zh., 47(8), 3 – 8 (2013); Pharm. Chem. J., 47(8), 399 – 404 (2013).

  5. R. W. DeSimone, K. S. Currie, S. A. Mitchell, et al., Comb. Chem. High Throughput Screen., 7(5), 473 – 494 (2004).

    Article  CAS  PubMed  Google Scholar 

  6. A. M. Simonov and V. N. Komissarov, Khimiya Geterotsikl. Soedin., 826 (1975).

  7. A. N. Kudrin and Ya. I. Zaidler, Farmakol. Toksikol., 31(1), 41 – 44 (1968).

  8. N. A. Gurova, A. A. Spasov, and A. S. Pitersen, Vestnik VolgGMU, 2(38), 70 – 72 (2011).

    Google Scholar 

  9. G. V. R. Born, Nature, 194, 927 – 929 (1962).

    Article  CAS  PubMed  Google Scholar 

  10. M. B. Plotnikov, A. A. Koltunov, and O. I. Aliev, Éksperim. Klin. Farmakol., 59(6), 54 – 55 (1996).

    CAS  Google Scholar 

  11. M. R. Sakaev, I. V. Mindukshev, E. E. Lesiovskaya, et al., Éksperim. Klin. Farmakol., 63(3), 65 – 69 (2000).

    CAS  Google Scholar 

  12. H. Nishio, A. Fujii, and Y. Nakata, Behav. Brain Res., 73(1 – 2), 301 – 304 (1996).

  13. A. A. Spasov, D. S. Yakovlev, T. M. Bukatina, and A. A. Brigadirova, Byul. Éksperim. Biol. Med., 158(7), 128 – 130 (2014).

    Google Scholar 

  14. H. L. Kuo., J. C. Lien, C. H. Chang, et al., Naunyn Schmidebergs Arch. Pharmacol., 6, 495 – 505 (2010).

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to O. N. Zhukovskaya.

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 51, No. 3, pp. 20 – 24, March, 2017.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhukovskaya, O.N., Anisimova, V.A., Spasov, A.A. et al. The Search for Pharmacologically Active Compounds Among the 2-Dialkylaminobenzimidazoles. Pharm Chem J 51, 182–186 (2017). https://doi.org/10.1007/s11094-017-1578-3

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-017-1578-3

Keywords

Navigation